Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The AAPS Journal
|
June 27, 2006
Discovery pharmaceutics--challenges and opportunities
Xue-Qing Chen, Melissa D Antman, Christoph Gesenberg, et al.
Journal of Pharmaceutical Sciences
|
April 12, 2024
Hydrolysis of cellulose acetate phthalate and hydroxypropyl methylcellulose phthalate in amorphous solid dispersions
Jinghan Li, Dongyue Yu, Chaowang Zeng, et al.
Journal of Pharmaceutical Sciences
|
April 5, 2014
Preclinical pharmacokinetics and in vitro metabolism of BMS-605339: a novel HCV NS3 protease inhibitor
Susan Jenkins, Paul Scola, Fiona McPhee, et al.
Pharmaceutical Research
|
April 21, 2021
Solvent-Casted Films to Assist Polymer Selection for Amorphous Solid Dispersions During Preclinical Studies: In-vitro and In-vivo Exploration
Laura I Mosquera-Giraldo, Maria Donoso, Kevin Stefanski, et al.
Molecular Pharmaceutics
|
January 15, 2026
Utilizing Flux to Inform Formulation Strategy Decisions in Preclinical Studies
Laura I Mosquera-Giraldo, Zina Patel, Dongyue Yu, et al.
Molecular Pharmaceutics
|
September 17, 2013
Assessing the risk of pH-dependent absorption for new molecular entities: a novel in vitro dissolution test, physicochemical analysis, and risk assessment strategy
Neil R Mathias, Yan Xu, Dhaval Patel, et al.
Pharmaceutical Research
|
October 23, 2019
Utilization of In Vitro, In Vivo and In Silico Tools to Evaluate the pH-Dependent Absorption of a BCS Class II Compound and Identify a pH-Effect Mitigating Strategy
Christoph Gesenberg, Neil R Mathias, Yan Xu, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 13, 2013
Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS-582949, a clinical p38α inhibitor
Chunjian Liu, James Lin, Gerry Everlof, et al.
Journal of Pharmaceutical Sciences
|
September 26, 2009
Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties
Zheng Yang, Lisa M Zadjura, Anthony M Marino, et al.
Journal of Medicinal Chemistry
|
September 12, 2015
Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carbonyl)(propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a Clinical Prodrug of p38α MAP Kinase Inhibitor
Chunjian Liu, James Lin, John Hynes, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The AAPS Journal
|
June 27, 2006
Discovery pharmaceutics--challenges and opportunities
Xue-Qing Chen, Melissa D Antman, Christoph Gesenberg, et al.
Journal of Pharmaceutical Sciences
|
April 12, 2024
Hydrolysis of cellulose acetate phthalate and hydroxypropyl methylcellulose phthalate in amorphous solid dispersions
Jinghan Li, Dongyue Yu, Chaowang Zeng, et al.
Journal of Pharmaceutical Sciences
|
April 5, 2014
Preclinical pharmacokinetics and in vitro metabolism of BMS-605339: a novel HCV NS3 protease inhibitor
Susan Jenkins, Paul Scola, Fiona McPhee, et al.
Pharmaceutical Research
|
April 21, 2021
Solvent-Casted Films to Assist Polymer Selection for Amorphous Solid Dispersions During Preclinical Studies: In-vitro and In-vivo Exploration
Laura I Mosquera-Giraldo, Maria Donoso, Kevin Stefanski, et al.
Molecular Pharmaceutics
|
January 15, 2026
Utilizing Flux to Inform Formulation Strategy Decisions in Preclinical Studies
Laura I Mosquera-Giraldo, Zina Patel, Dongyue Yu, et al.
Molecular Pharmaceutics
|
September 17, 2013
Assessing the risk of pH-dependent absorption for new molecular entities: a novel in vitro dissolution test, physicochemical analysis, and risk assessment strategy
Neil R Mathias, Yan Xu, Dhaval Patel, et al.
Pharmaceutical Research
|
October 23, 2019
Utilization of In Vitro, In Vivo and In Silico Tools to Evaluate the pH-Dependent Absorption of a BCS Class II Compound and Identify a pH-Effect Mitigating Strategy
Christoph Gesenberg, Neil R Mathias, Yan Xu, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 13, 2013
Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS-582949, a clinical p38α inhibitor
Chunjian Liu, James Lin, Gerry Everlof, et al.
Journal of Pharmaceutical Sciences
|
September 26, 2009
Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties
Zheng Yang, Lisa M Zadjura, Anthony M Marino, et al.
Journal of Medicinal Chemistry
|
September 12, 2015
Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carbonyl)(propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a Clinical Prodrug of p38α MAP Kinase Inhibitor
Chunjian Liu, James Lin, John Hynes, et al.
Page
of 2